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The cytotoxicity of different samples of carbon nanotubes synthesised by catalytic chemical
vapour deposition was investigated towards human umbilical vein endothelial cells, using two
cytotoxicity standard tests (neutral red assay for the cell viability and MTT assay—tetrazolinium
salt—for the cell metabolic activity). No toxicity was found for any sample, although a slight
dilution effect may exist for two of them.
In the heart of the dispute about the possible negative
effects of nanotechnologies and the potential toxicity of
nano-scale objects, the question of the cytotoxicity of
carbon nanotubes (CNTs) is very relevant. Before CNTs
can be used in medical applications such as drug-delivery
agents for example, their innocuity towards the human
body has to be assessed. Compared to the abundant lit-
erature dealing with the synthesis, characterisation and
possible applications of CNTs, it is striking to note the
lack of data on their possible bio-toxicity. It is important
to keep in mind that CNTs can be produced by differ-
ent methods, the main three ones being the electric arc-
discharge [1], Laser ablation [2] and Catalytic Chemical
Vapour Deposition (CCVD) [3–5]. Each method gives
CNTs of different kind and all require the use of metals
as catalysts. As a general trend, arc-produced CNTs tend
to be about 1 µm long and to gather into large bundles up
to more than 100 CNTs. These CNTs are generally very
straight and, said to be free of structural defects. They are
produced together with carbon soot containing amongst
others fullerenes and graphitic particles. Laser ablation
produces purer samples (containing fewer by-products)
and the CNTs form very long and large bundles, up to
hundreds of µm long. CCVD CNTs are forming smaller
bundles, with a length generally ranging between a few
tens to hundreds of micrometers. The diameter distribu-
tion is ranging between less than 1 nm to 4–5 nm, as
opposed to the arc-discharge and laser ablation methods
where the diameter distribution is narrower and mainly
centred around 1.3 nm. Each synthesis method produces
a different quality of CNTs, the term of quality involving
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the chemical purity (residual catalyst—mainly transition
metals—and presence or not of other forms of carbon
species such as amorphous carbon and graphitic-like par-
ticles) and the structural quality of the CNTs. The control
of the number of walls of the CNTs and the diameter dis-
tribution can also be seen as a sort of purity (in terms of
selectivity).
The first study (published in 2001) by Huczko et al. [6]
was focusing on the comparison between arc-discharge
produced CNTs and asbestos fibres. CNTs were intro-
duced in guinea pigs by intratracheal instillation (suspen-
sion in sterile saline media with addition of surfactant).
The results of the bronchoalveolar lavage examinations
4 weeks after the instillation revealed no change in the
pulmonary function and did not induce any measurable
inflammation in bronchoalveolar space, concluding to the
innocuity of the tested samples.
Shvedova et al. [7] have investigated the assessment of
raw-CNTs cytotoxicity using human keratinocyte cells,
showing that the dermal exposure to raw CNTs may lead
to dermal toxicity due to accelerated oxidative stress in the
skin, mainly because of important amounts of iron in the
studied samples (HiPCO CNTs, CCVD process). Another
study by the same group [8] has compared the aerosols
formed during the handling of different CNTs samples
(HiPCO, laser ablation) and has shown that the airborne
concentrations were generally lower than 53 µg·m−3. It
is only very recently in 2004 that the last two reports on
the toxicological effects of CNTs have been issued, both
based on a comparative toxicological approach and in-
tratracheal instillation route of exposure to examine the
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pulmonary toxicity of single-walled CNTs (SWNTs).
Lam et al. [9] focused on the histopathological alter-
ations in mice 7 and 90 days after the exposure to CNTs,
produced by two different CCVD methods and contain-
ing various amounts of residual catalytic metals (Fe, Co,
Ni, Mo, etc.). They reported that CNTs could be more
dangerous than quartz particles and that all the CNTs
tested induced lung lesions characterised by the presence
of granulomas. They also suggested that the metal con-
taminants could not be the only cause. Warheit et al.
[10] studied the ability of CNTs to induce pulmonary
inflammation as well as to alter lung cellular prolifera-
tion. They confirmed the formation of granulomas after
instillation of SWNTs (laser-ablation produced soot con-
taining about 60% SWNTs) and revealed that the unique
mechanical and chemical properties of CNTs make them
more persistent in biological systems. Pantarotto et al.
[11] reported the translocation of water soluble SWNT
derivatives across cell membranes and have shown that
cell death can be induced by functionalised CNTs (bioac-
tive peptides), depending on their concentration in the
media.
We report here the study of the cytotoxicity of differ-
ent samples of carbon nanotubes synthesised by CCVD.
We took advantages of two existing standard tests, Neutral
Red assay for the cell viability and MTT assay (tetrazolin-
ium salt) for the cell metabolic activity. These tests are
optimized for indirect cytotoxicity and we adapted them
to test the effect of the CNTs on cells. Human umbilical
vein endothelial cells (HUVEC) are especially good can-
didates for these tests, because CNTs are often thought
to be injected in the human body to be carried to targeted
places by the blood.
The CNTs were prepared by Catalytic Chemical
Vapour Deposition using bimetallic MgO-based cata-
lysts [5, 12]. Mg1−x(CoyM1−y)xO catalysts were prepared
by combustion synthesis [12]. The different composi-
tions were as follows: x = 0.01 with y = 0.75 and
M = Mo (sample A) or W (sample B); x = 0.05 with
y = 0.9 and M = Mo (sample C). Magnesium and cobalt
nitrates were dissolved in deionised water and the required
amount of (NH4)6Mo7O24· 4H2O or Na2WO4· 2H2O was
added to the solution. Citric acid was used as the fuel,
using the stoechiometric proportion [13]. For each ex-
periment, 1.5 g of the starting oxide was reduced in a
H2-CH4 mixture (18 mol% CH4, heating and cooling rates
5◦C/min, maximum temperature 1000◦C, no dwell). This
resulted in a mat of composite powder (which density de-
pended on the composition of the catalyst), which was
then treated with a concentrated aqueous HCl solution
(12M) to separate the CNTs by dissolving all the remain-
ing oxide material, as well as unprotected metal particles
[5, 12]. The suspensions were filtered and washed on
cellulose nitrate membranes (Whatman, 0.45 µm) with
deionised water until neutrality. The samples were dried
overnight in air in an oven at 80◦C, yielding different
amounts of CNTs according to the composition of the
corresponding catalyst. The samples were characterised
by electron microscopy (scanning and transmission); the
specific surface area (noted Se, m2·g−1) was measured
by the BET method using N2 adsorption at liquid N2
temperature (Micromeritics FlowSorb II 2300) and the
carbon content (noted Ce, wt%) was obtained by elemen-
tal analysis (flash combustion). The main characteristics
of the different CNTs samples are detailed in Table I.
Fig. 1 shows typical electron microscope images of the
CNTs samples before the elimination of the oxide cata-
lyst (which can be seen in SEM images: 1a, c, d). These
images reveal a high density of CNTs in all three samples.
Fig. 1b (TEM) shows that the filaments observed by SEM
are in fact small-diameter bundles of CNTs. Careful anal-
ysis of high-resolution TEM images allowed the measure
of the number of walls and diameter of the CNTs (Fig. 2).
Sample A (Fig. 2a, 96 individual CNTs imaged) contains
CNTs having between 1 and 3 walls, with more than 75%
double-walled CNTs (DWNTs) and outer diameters rang-
ing from 1.1 to 3.2 nm (Fig. 2d). Sample B (Fig. 2b, 164
individual CNTs imaged) contains CNTs having between
1 and 4 walls, with 37% DWNTs, 48% triple-walled CNTs
(TWNTs) and 12% CNTs with 4 walls. The outer diam-
eters are ranging from 1.1 to 4.3 nm (Fig. 2e). Sample
C (Fig. 2c, 183 individual CNTs imaged) contains CNTs
having between 1 and 6 walls, with 9% single-walled
CNTs (SWNTs), 72% DWNTs and 15% TWNTs. The
outer diameters are ranging from 0.7 to 6.3 nm (Fig. 2f).
Primary cultures of human umbilical vein endothelial
cells (HUVEC) were prepared and cultured as previously
described [14]. HUVEC were submitted to the samples
by the way of fragments of sterile (autoclaved: 121◦C -
20 min) material. HUVEC were seeded at a density of
6,000 cells per cm2 in 96-well microtiter plates (Nunc,
Denmark) and the culture was maintained at 37◦C after
cell plating until confluency was reached. At confluency
the medium was replaced by the material samples. To
obtain such samples, fragments of sterile material were
immersed in culture medium (IMDM) in order to obtain
TAB LE I Characteristics of the CNTs samples. The catalyst composition is the elemental one, although these catalysts are not solid solutions [CC]
Outer Ø(nm)
Reference Catalyst composition Se (m2·g−1) Ce (wt %) Range Mean value
A Mg0.99(Co0.75Mo0.25)0.01O 1110 92.8 1.2–3.2 2.01
B Mg0.99(Co0.75W0.25)0.01O 790 90.4 1.0–4.3 3.11
C Mg0.95(Co0.90Mo0.10)0.01O 550 80.2 0.7–6.3 2.37
Figure 1 Typical images of the CNTs samples before the elimination of the oxide catalyst (which can be seen in the background). Sample A observed by
SEM (a) and TEM (b); note the small diameter of the bundles of CNTs. Typical SEM images of samples B (c) and C (d).
5 cm2 of the sample surface to 1 mL of IMDM (Iscove
Modified Dulbecco’s Medium) according to the standards
of indirect cytotoxicity. Samples were treated in borosil-
icate glass tubes at 37◦C for 120 h and 5% CO2 without
stirring according to the standard procedures. Borosilicate
tubes containing IMDM with either no material or a solu-
tion of phenol at a concentration of 64 g·L–1 (known to be
cytotoxic) were processed under the same conditions to
provide negative and positive controls, respectively. When
HUVEC confluency was reached, the culture medium was
removed and replaced by the samples at various dilutions
[100% (v/v), 50% (v/v), 10% (v/v), 1% (v/v)] in the cul-
ture medium and supplemented with 10% FCS (Foetal
Calf serum) for 24 h at 37◦C and 5% CO2. At the end
of the incubation period, the supernatants (material or
control samples) were discarded, and two different as-
says [15–18] were performed: cell viability (Neutral Red
assay) and cell metabolic activity (MTT assay). The in-
tensity of the colours obtained (red and blue respectively)
is directly proportional to the viability and metabolic ac-
tivity of cell populations and inversely proportional to the
toxicity of the material. For the statistical analyses, values
are expressed as mean ± SD. The statistical significance
was tested by an unpaired Student t test and p < 0.05 was
considered significant.
Data obtained from the biocompatibility studies follow-
ing incubation of cells with CNTs suspensions were ex-
pressed for Neutral Red and MTT assays as a percentage
of the values obtained from cells incubated with negative
control extracts. Phenol (64 g·L−1) was used as a toxic
control. Fig. 3 compares the results (given in percent of the
response to the test compared to an untreated control blank
sample) of the cell viability (Neutral Red assay, Fig. 3a)
and cell metabolic activity (MTT assay, Fig. 3b). Any re-
sponse below the dotted line at 75% of the response of
the blank sample may be considered as cytotoxic. The re-
sults of the cells viability test (Fig. 3a) indicated that none
of the samples was found to be cytotoxic, although for
samples A and B the error bars sometimes extend below
the cytotoxicity threshold (75%). There may be a slight
dilution effect for samples A and B, with the HUVEC
viability decreasing with the dilution, as confirmed by a
significant statistical difference between diluted samples
(measures indicated by a star in Fig. 3a) and the samples
considered as “pure” (100%). The cell metabolic activity
test (Fig. 3b) confirmed that none of the sample shown a
cytotoxic effect but revealed no obvious dilution effect.
HUVEC were chosen in this study because of their pos-
sible future contact with CNTs when intravenous route
is envisaged and because such cells are very sensitive
Figure 2 Distribution of the numbers of walls (a–c) and the inner (di) and outer (do) diameter (d–f) for each sample (whole population of CNTs). Sample
A (a, d, respectively), sample B (b, e, respectively) and sample C (c, f, respectively).
to modifications of their environment. Indeed, they are
known to respond quickly to various stimuli (biochemi-
cal, mechanical) and are thus good indicative cells [19] of
a possible cytotoxicity effect.
The biocompatibility tests performed in this study
required the use of very small concentrations of
CNTs (5 cm2·mL–1 for the most concentrated suspen-
sion). Because the specific surface area of each CNTs
sample was different (and very high), the concentration
in weight per volume was different for each of them.
The concentrations for the more concentrated suspen-
sions were thus close to 0.5 µg·mL–1 for sample A,
0.64 µg·mL–1 for sample B and 0.9 µg·mL−1 for sam-
ple C. Several successive dilutions were required to reach
such low concentrations and systematic errors thus accu-
mulate. Although the samples were prepared very care-
fully, the question of the validity of these widely used
standard tests may be questioned in the case of high spe-
cific surface area nanomaterials such as CNTs.
The question of the chemical purity of the samples
has already been raised: is the toxicity coming from the
CNTs themselves or from residual catalysts still present
in the purified samples? Lam et al. [9] suggested that
the metal contaminants could not be the only cause
of the toxicity, in agreement with the results of this
study because the only sample showing no cytotoxic-
ity at any concentration is the one which contains the
more residual metal nanoparticles. These metal nanopar-
ticles are in fact encapsulated by graphene-like layers
and thus efficiently protected against their environment
[20]; the metals should thus never be in contact with the
biological material. If the toxicity does not come from
carbon-encapsulated residual catalyst, it may rather come
from the structural characteristics of the CNTs, such as
their gathering into bundles of different diameter and their
outer diameter distribution. In terms of bundling, one can
imagine that the lower the concentration of the disper-
sion, the higher the dispersion of the CNTs and thus the
Figure 3 HUVEC Viability (a) and Metabolic activity (b) tests for samples
A, B and C. Results expressed in percentage of the answer of the untreated
control sample and compared to phenol (cytotoxic reference); A star (∗)
indicates that the value is statistically different from sample 100%.
smaller the diameter of the bundles. A lower concentra-
tion would favour a higher dispersion of the CNTs which
may improve their interactions with the cells and thus
possibly lead to some possible toxicity. The question of
the outer diameter distribution of the CNTs is important
as well. The response of the three samples to the tests does
not show any clear correlation with the mean diameter of
the CNTs populations. In fact, this is probably because
the diameter of the CNTs has no relationship with the
size of the HUVEC, which are adherent cells of cobble-
stone morphology in such culture conditions, with a mean
size usually ranging from 30 to 50 µm on the culture sup-
port. Such small variations of the CNTs outer diameter
distribution should thus have no consequence. About the
effect of concentration, Pantarotto et al. [11] and May-
nard et al. [8] also worked with different concentrations
of CNTs and both claimed a lower toxicity when the con-
centration was decreased (in the case of Pantarotto, the
real CNTs concentration is unknown and in the case of
Maynard, it is mainly the contamination with Fe which is
responsible for the toxicity); it is possible (although sta-
tistically relevant for samples A and B) that in the present
study the possible dilution effect observed could be only
fortuitous and may fall within the experimental error. The
results of the MTT assay would agree with this second
explanation. Experiments to confirm this observation are
currently in progress.
The inflammatory response of the cells has not been
investigated in this study but would be important to know.
We do not have any data about the possible endocytosis of
CNTs by the cells but Pantarotto et al. [11] have reported
that functionalised CNTs are able to cross the cell mem-
brane and to accumulate in the cytoplasm or even reach
the nucleus without being toxic for the cell at low enough
concentration. The exact concentration of the CNTs sus-
pensions was not given but it was reported that the toxicity
appeared with increasing the concentration, which is dif-
ferent from the results presented here. However, there are
two main differences between these studies because (i)
Pantarotto et al. [11] used very short CNTs (0.3 to 1 µm
long), probably synthesised by the arc-discharge process
(not indicated) and (ii) these CNTs were functionalised
by bioactive peptides. The length of the CNTs used in
this work is more likely to be ranging between 5 µm and
up to 100 µm, which may make an important difference.
A microscopy study of the HUVEC after the cytotoxicity
test would give important information about the possible
endocytosis of non-functionalised CNTs.
In summary, the cytocompatibility study of three
CCVD-synthesised CNTs samples was investigated by
two standard tests (Neutral Red and MTT assays). It re-
vealed no cytotoxic effect according to the standards of
the method. However, we have observed that for the CNTs
having the highest specific surface area, a cytotoxicity ef-
fect seems to appear slowly with increasing the dilution of
the suspension. This dilution effect may be related to the
amount of CNTs present in the suspensions (the higher
the specific surface area, the lower the amount of CNTs)
and/or to bundling effects. Although these results do not
indicate any cytotoxicity towards HUVEC, and because
each CNTs sample is different (presence of residual met-
als or additional carbon contamination such as graphitic-
like particles and/or amorphous carbon deposits), the han-
dling of CNTs should always be done in safe conditions
by wearing gloves and appropriate respiratory protection.
The results of the study of the cytotoxicity of a given
sample could probably not be extrapolated without risk
to another sample prepared using a different technique or
even from a different catalyst for the same synthesis pro-
cess. Potential physical damages to the cells and the likely
chemical stability of CNTs in the human body incite to
carefulness but the results of this study however suggest
that the vectorisation of substances by CNTs via injection
in the blood circulation seems conceivable.
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